Brief pearls for diagnosis and management of ascites and relevant conditions associated with decompensated cirrhosis.Read More
Results from a large, single-center, retrospective study have multiple implications for preventive care for patients with celiac disease and COVID-19.
The unique program addresses an unmet need and now looks to expand following its successful first year.
Imaging reveals a large spindle cell sarcoma invading the lumbar spine and left common iliac vein in a 51-year-old. Resection risks damage to critical vasculature and would require removing a significant amount of spine.
Leading-edge surgical approaches are enabling Cleveland Clinic’s living donor liver transplant program to safely and successfully utilize small-size donor grafts, especially left lobes. Here’s how.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A new study illustrates why it’s important for clinicians to be aware and suspicious of tip of the J-pouch leaks.
Anthony Lembo, MD, has been named Director of Research for Cleveland Clinic’s Digestive Disease & Surgery Institute and will prioritize a renewed focus on mentorship as part of his three-step plan.
New research assessing colonoscopy’s benefits in population screening is causing some to question the procedure’s value. Based on a close look at the findings, that’s an overreaction, a Cleveland Clinic colorectal surgeon contends.
Cleveland Clinic has created the multidisciplinary Neurogastroenterology and Motility Center to provide comprehensive specialized care and conduct research involving complex disorders that have a neural basis and affect control of digestion and the gastrointestinal system.
Findings from a long-term study highlight the associated complications of disconnected or disrupted PD and underscore the importance of preventing PD recurrences.
The incidence of gastroenteropancreatic neuroendocrine tumors is on the rise. Cleveland Clinic’s growing program will be a hub for patients and providers, led by Michelle Kang Kim, MD, PhD, one of the only U.S. gastroenterologists specializing in neuroendocrine tumors.